Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China

Author:

Guo Jun1,Zha Lei23,Zeng Kai4,Shao Mingyu5,Chen Dan6,Wang Bing7,Zhou Yun8,Yang Gang8,Zhang Xue1,Zou Xia9,Zhang Yan1,Kang Yan1

Affiliation:

1. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China

2. Intensive Care Unit, Conch Hospital of Anhui Medical University, Wuhu, Anhui 241000, China

3. Institute of Infection and Global Health, University of Liverpool, L69 7BE, Liverpool, UK

4. Critical Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, China

5. Hospital Administration Office, Jilin Central General Hospital, Jilin, Jilin 132000, China

6. Medical Administration Department, Jilin Central General Hospital, Jilin, Jilin 132000, China

7. Department of Cardiology, Jilin Central General Hospital, Jilin, Jilin 132000, China

8. Department of Pulmonary and Critical Care, Wuhu Hospital, East China Normal University, Wuhu, Anhui 241000, China

9. Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3